Dopaminergic abnormalities borderline essential hypertensive patients altered metabolic pathway dihydroxyphenylalanine DOPA dopamine abnormalities borderline hypertension basal DOPA-induced mg changes blood pressure pulse rate hourly plasma urine samples borderline hypertensive patients controls baseline urinary excretion methoxytyramine marker exocytotic dopamine release DOPA-induced decrease systolic blood pressure reflex tachycardia response blunted plasma DOPA free dopamine increase accentuated plasma dopamine sulfate urinary DOPAC excretion comparable quantities dopamine urine rise glomerular DOPA load DOPA natriuresis groups effect borderline hypertensive patients urinary sodium correlation urinary dopamine excretion control subjects data compatible increased basal exocytotic dopamine release neuronal renal extraneuronal dopamine generation DOPA borderline hypertension DOPA-induced hypernatriuresis augmented dopamine borderline hypertensive patients urinary sodium dopamine correlation control subjects DOPA additional natriuresis borderline hypertensive patients decrease renal sympathetic tone central inhibition sympathetic outflow absence reflex tachycardia 